Position in PGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$516,733
New position
Shares Held
90,655
first reported quarter
Ownership
0.025%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#92
of 208 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 8%
Shared 0%
None 92%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Integrated Quantitative Investments LLC holds $8,725,728 across 13 Biotechnology names. PGEN ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
90,718 | $2,492,023 | |
| 2 | RAPP |
Rapport Therapeutics, Inc.
|
30,386 | $1,266,184 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
3,173 | $1,062,288 | |
| 4 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
146,065 | $911,445 | |
| 5 | PGEN |
Precigen, Inc.
This page
|
90,655 | $516,733 | |
| 6 | CLYM |
Climb Bio, Inc.
|
31,406 | $409,534 | |
| 7 | ABUS |
Arbutus Biopharma Corp
|
79,937 | $383,697 | |
| 8 | INCY |
Incyte Corp
|
3,301 | $374,201 |
All Filings in PGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $516,733 | 90,655 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||